ESR2 and breast carcinoma: Recently, the question of whether ERβ is expressed in normal breast or breast cancer at all, was raised in a comprehensive study reporting that only the rarely used monoclonal antibody PPZ0506 specifically targets ERβ in immunohistochemistry [49].